FANCD2 and glioblastoma: In this study, we assessed the underlying roles of FANCD2 in the immune response of GBM patients and found that aberrant FANCD2 might regulate multiple immune-associated signatures in GBM pathogenesis, such as immune-stimulators, immune-inhibitors, chemokines, and their receptors.